SMART-METRO: Technical Capabilities of the "SMART ANGEL Intra-hospital" System 's Connected Medical Device (CMD)

Sponsor
Assistance Publique - Hôpitaux de Paris (Other)
Overall Status
Unknown status
CT.gov ID
NCT04668807
Collaborator
EVOLUCARE (Other), InES - Innovation Electronic Software (Other)
100
1
2
6
16.7

Study Details

Study Description

Brief Summary

Post-operative mortality in case of scheduled surgery is 3% in France (Lancet 2013) mainly due to cardiovascular or respiratory complications, by decompensation of pre-existing pathologies.

Complications due to the medical practice are the third cause of morbidity(BMJ, 2016). More than half are preventable and are mainly observed in surgical patients. In conventional hospitalization, excluding intensive care, monitoring is done discontinuously for most of the patients, which does not allow early diagnosis of a vital cardiovascular or respiratory failure.

Diagnosis and late treatment do not allow good recovery. The early identification of a vital failure by the continuous monitoring of three simple physiological parameters (SpO2, heart rate and respiratory rate) would allow faster management by the hospital staff and a reduction in immediate and possibly delayed postoperative mortality.

Condition or Disease Intervention/Treatment Phase
  • Device: Connected Medical Device
  • Device: Traditional transmission system
N/A

Detailed Description

The challenge of this research is to transpose in an ordinary hospitalization unit the continuous monitoring of vital functions carried out in intensive care by the continuous measurement of simple parameters using a Connected Medical Device (CMD).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Measurement of 3 constants (SpO2, heart rate and respiratory rate) in patients with a non-ambulatory surgical or interventional act lasting more than 2 hours whose constants are monitored by the reference device in the operating room and the Connected Medical Device.Measurement of 3 constants (SpO2, heart rate and respiratory rate) in patients with a non-ambulatory surgical or interventional act lasting more than 2 hours whose constants are monitored by the reference device in the operating room and the Connected Medical Device.
Masking:
None (Open Label)
Primary Purpose:
Device Feasibility
Official Title:
Assessment of the Technical Capabilities of the "SMART ANGEL" Intra-hospital System 's Connected Medical Device (CMD)
Anticipated Study Start Date :
Dec 1, 2020
Anticipated Primary Completion Date :
Jun 1, 2021
Anticipated Study Completion Date :
Jun 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Connected Medical Device

"SMART ANGEL Intra-hospital" System 's Connected Medical Device (DMC) measuring physiological parameters in the operating room

Device: Connected Medical Device
Monitoring of three simple physiological parameters (SpO2, heart rate and respiratory rate) with a Connected Medical Device (DMC) in the operating room

Active Comparator: Traditional system

Traditional wired transmission system between the sensor and the data processing device in the operating room

Device: Traditional transmission system
Monitoring of physiological parameters with a traditional wired transmission system between the sensor and the data processing device in the operating room

Outcome Measures

Primary Outcome Measures

  1. Agreement between the values measurements produced by the traditional monitoring system in the operating theater and the connected medical device of the "SMART ANGEL intra-hospital" system [at 2 hours]

Secondary Outcome Measures

  1. Evaluation of missing data due to device malfunction [at 2 hours]

  2. Nurse satisfaction (System Usability Scale) [at 2 hours]

  3. Occurrence of events during the course of the study [at 2 hours]

  4. Time needed by the nursing staff to set up the system [at 2 hours]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age ≥ 18 years

  • Patients receiving a non-ambulatory surgical or interventional procedure lasting more than 2 hours

  • Affiliation with a social security syste, beneficiarie or eligible people (excluding State Medical Assistance (AME))

  • Written consent of the patient

Exclusion Criteria:
  • Patient carrying a multi-resistant germ and placed in isolation

  • Patient's known linguistic inability to understand the study

  • Non-ambulatory surgical or interventional act in an emergency situation

  • Patients under legal protection : curatorship or guardianship

  • Known pregnancy or nursing woman

  • Patients with implantable cardiac pacemakers, implantable defibrillators or neurostimulators

Contacts and Locations

Locations

Site City State Country Postal Code
1 Assistance Publique Hôpitaux de Paris - CHU Henri Mondor Créteil France 94 010

Sponsors and Collaborators

  • Assistance Publique - Hôpitaux de Paris
  • EVOLUCARE
  • InES - Innovation Electronic Software

Investigators

  • Principal Investigator: Jean-Louis MARTY, MD, PhD, Assistance Publique - Hôpitaux de Paris

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT04668807
Other Study ID Numbers:
  • APHP190708
  • 2019-A02197-50
First Posted:
Dec 16, 2020
Last Update Posted:
Dec 16, 2020
Last Verified:
Feb 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Assistance Publique - Hôpitaux de Paris

Study Results

No Results Posted as of Dec 16, 2020